Strength
500 ug/1
Manufacturer
Major PharmaceuticalsNDC
00904739946
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ROFLUMILASTApproval Type
Generic (ANDA)
FDA Application
ANDA208256On Market Since
12/26/2023
Pharmacological Classes
Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors
ROFLUMILAST 500 MCG TABLET
Generic
60687078621•American Health Packaging
$0.3187
ROFLUMILAST 500 MCG TABLET
Generic
67877048090•Ascend Laboratories, LLC
$0.3187
ROFLUMILAST 500 MCG TABLET
Generic
31722062390•Camber Pharmaceuticals Inc.
$0.3187
ROFLUMILAST 500 MCG TABLET
Generic
00904748389•Major Pharmaceuticals
$0.3187
ROFLUMILAST 500 MCG TABLET
Generic
42571025930•Micro Labs Limited
$0.3187
ROFLUMILAST 500 MCG TABLET
Generic
72205020030•Novadoz Pharmaceuticals LLC
$0.3187
ROFLUMILAST 500 MCG TABLET
Generic
68382096916•Zydus Pharmaceuticals (USA) Inc.
$0.3187
Related Drugs
Same classification
ROFLUMILAST 500 MCG TABLET
Generic
43547000503•Solco Healthcare US LLC
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
43547000509•Solco Healthcare US LLC
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
59651027530•Aurobindo Pharma Limited
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
59651027590•Aurobindo Pharma Limited
$0.3187
per EA
ROFLUMILAST 250 MCG TABLET
Generic
42571036983•Micro Labs Limited
$1.9621
per EA